Press Releases

Verdesian Life Sciences, LLC Acquires QC Corporation

October 1, 2014

Benesch represented Verdesian Life Sciences, LLC in its acquisition of QC Corporation. The combined company will continue to be owned by and have the capital backing of Paine & Partners, a private equity firm that invests globally in food and agribusiness companies.

Founded in 2012, Verdesian Life Sciences offers patented biological, nutritional, seed treatment and inoculant technologies for high-value specialty crops, row crops and turf and ornamental markets. Verdesian’s plant-health products, nutritional catalysts and seed treatments/inoculants help growers farm more efficiently to maximize yields. Verdesian’s technologies answer the needs facing agriculture including increasing pressures on food demand, supply and food safety. Verdesian remains committed to the research and development of environmentally sustainable products.

QC Corporation is a leading producer and supplier of granular and dry micronutrients and ferrous sulfate products.

The Benesch team was led by Leslie A. Drockton and Michael A. Primrose.

Latest News

Press Releases 6.2.26

Benesch Government Relations Partner Holly Gross Named a 2026 Women of Influence by Columbus Business First

Benesch is pleased to announce that Government Relations Partner Holly Gross has been named among Columbus Business First’s 2026 Women of Influence in the Trailblazer category. This recognition honors women who are pioneers or firsts in their field and who have broken new ground, opened doors for others or led innovation in industries where women may be underrepresented.

Press Releases 5.20.26

Daily Journal Names Benesch Partner Charan Brahma a 2026 Top Intellectual Property Lawyer

Benesch is pleased to announce that Intellectual Property Partner Charan Brahma has been named to the Daily Journal’s 2026 Top Intellectual Property Lawyers list. Charan focuses his practice on patent litigation and a range of intellectual property matters, primarily representing pharmaceutical and technology clients. With a strong trial focus, he works closely with clients to develop efficient litigation strategies aligned with their business objectives.